Tiziana life sciences plc: pdmr dealing

London and new york, oct. 20, 2021 (globe newswire) -- tiziana life sciences plc (nasdaq: tlsa / lse: tils) ("tiziana" or the "company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has been notified that panetta partners limited, an entity in which gabriele cerrone, the executive chairman has a beneficial interest, purchased 60,000 ordinary shares of 3p each in the market at a price of 55p per share.
TLSA Ratings Summary
TLSA Quant Ranking